Michael Liontos
Cited by
Cited by
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
J Bartkova, N Rezaei, M Liontos, P Karakaidos, D Kletsas, N Issaeva, ...
Nature 444 (7119), 633-637, 2006
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
R Di Micco, G Sulli, M Dobreva, M Liontos, OA Botrugno, G Gargiulo, ...
Nature cell biology 13 (3), 292-302, 2011
Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation
M Ogrunc, R Di Micco, M Liontos, L Bombardelli, M Mione, M Fumagalli, ...
Cell Death & Differentiation 21 (6), 998-1012, 2014
Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy
S Miyakis, G Karamanof, M Liontos, TD Mountokalakis
Postgraduate medical journal 82 (974), 823-829, 2006
Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior
M Liontos, M Koutsami, M Sideridou, K Evangelou, D Kletsas, B Levy, ...
Cancer research 67 (22), 10899-10909, 2007
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
L Weisz, A Damalas, M Liontos, P Karakaidos, G Fontemaggi, ...
Cancer research 67 (6), 2396-2401, 2007
Atezolizumab, bevacizumab, and chemotherapy for newly diagnosed stage III or IV ovarian cancer: placebo-controlled randomized phase III trial (IMagyn050/GOG 3015/ENGOT-OV39)
KN Moore, M Bookman, J Sehouli, A Miller, C Anderson, G Scambia, ...
Journal of Clinical Oncology 39 (17), 1842, 2021
Angiogenesis-related pathways in the pathogenesis of ovarian cancer
NG Gavalas, M Liontos, SP Trachana, T Bagratuni, C Arapinis, C Liacos, ...
International journal of molecular sciences 14 (8), 15885-15909, 2013
Systemic therapy in cervical cancer: 30 years in review
M Liontos, A Kyriazoglou, I Dimitriadis, MA Dimopoulos, A Bamias
Critical reviews in oncology/hematology 137, 9-17, 2019
Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
G Velimezi, M Liontos, K Vougas, T Roumeliotis, J Bartkova, M Sideridou, ...
Nature Cell Biology 15 (8), 967-977, 2013
SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1
SA Woodcock, C Rooney, M Liontos, Y Connolly, V Zoumpourlis, ...
Molecular cell 33 (5), 639-653, 2009
Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins
M Sideridou, R Zakopoulou, K Evangelou, M Liontos, A Kotsinas, ...
Journal of Cell Biology 195 (7), 1123-1140, 2011
Advanced small cell lung cancer (SCLC): new challenges and new expectations
N Tsoukalas, E Aravantinou-Fatorou, P Baxevanos, M Tolia, K Tsapakidis, ...
Annals of translational medicine 6 (8), 2018
Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non‐small cell lung cancer
K Apostolopoulou, IS Pateras, K Evangelou, PK Tsantoulis, M Liontos, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive …
A Bamias, K Tzannis, LC Harshman, SJ Crabb, YN Wong, SK Pal, ...
Annals of Oncology 29 (2), 361-369, 2018
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
K Evangelou, J Bartkova, A Kotsinas, IS Pateras, M Liontos, G Velimezi, ...
Cell Death & Differentiation 20 (11), 1485-1497, 2013
Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas
M Liontos, K Niforou, G Velimezi, K Vougas, K Evangelou, ...
The American journal of pathology 175 (1), 376-391, 2009
Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF‐κB pathway
F Sigala, P Savvari, M Liontos, P Sigalas, IS Pateras, A Papalampros, ...
Journal of cellular and molecular medicine 14 (9), 2273-2280, 2010
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised …
K Fizazi, G Kramer, JC Eymard, CN Sternberg, J De Bono, D Castellano, ...
The Lancet Oncology 21 (11), 1513-1525, 2020
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European …
A Bamias, K Tzannis, A Papatsoris, S Oudard, B Beuselinck, B Escudier, ...
Clinical genitourinary cancer 12 (5), 373-383, 2014
The system can't perform the operation now. Try again later.
Articles 1–20